These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34365891)

  • 21. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis.
    Liu XX; Zhang J; Zheng JY; Zhang S; Xu YS; Kang DX; Fan DS
    Muscle Nerve; 2009 Mar; 39(3):304-9. PubMed ID: 19208412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study.
    de Carvalho M; Swash M
    Muscle Nerve; 2010 Feb; 41(2):208-11. PubMed ID: 19697379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrical impedance myography (EIM) in a natural history study of
    Offit MB; Wu T; Floeter MK; Lehky TJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):445-451. PubMed ID: 32312103
    [No Abstract]   [Full Text] [Related]  

  • 25. Brain plasticity in the motor network is correlated with disease progression in amyotrophic lateral sclerosis.
    Poujois A; Schneider FC; Faillenot I; Camdessanché JP; Vandenberghe N; Thomas-Antérion C; Antoine JC
    Hum Brain Mapp; 2013 Oct; 34(10):2391-401. PubMed ID: 22461315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients.
    Nakamura R; Atsuta N; Watanabe H; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Tanaka F; Izumi Y; Morita M; Ogaki K; Taniguchi A; Aiba I; Mizoguchi K; Okamoto K; Hasegawa K; Aoki M; Kawata A; Abe K; Oda M; Konagaya M; Imai T; Nakagawa M; Tsuji S; Kaji R; Nakano I; Sobue G
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1365-71. PubMed ID: 23933739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
    Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
    Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The checklist individual strength (CIS20-R) in patients with amyotrophic lateral sclerosis - a longitudinal study.
    Panitz S; Kornhuber M; Hanisch F
    Acta Neurol Scand; 2015 Jun; 131(6):372-80. PubMed ID: 25639482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis.
    Beghi E; Balzarini C; Bogliun G; Logroscino G; Manfredi L; Mazzini L; Micheli A; Millul A; Poloni M; Riva R; Salmoiraghi F; Tonini C; Vitelli E;
    Neuroepidemiology; 2002; 21(6):265-70. PubMed ID: 12411728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life and motor impairment in ALS: Italian validation of ALSAQ.
    Palmieri A; Sorarù G; Lombardi L; D'Ascenzo C; Baggio L; Ermani M; Pegoraro E; Angelini C
    Neurol Res; 2010 Feb; 32(1):32-40. PubMed ID: 20092693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and electrophysiological examination of pinch strength in patients with amyotrophic lateral sclerosis.
    Lee JD; Heshmat S; Heggie S; Thorpe KA; McCombe PA; Henderson RD
    Muscle Nerve; 2021 Jan; 63(1):108-113. PubMed ID: 33118631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D in amyotrophic lateral sclerosis.
    Libonati L; Onesti E; Gori MC; Ceccanti M; Cambieri C; Fabbri A; Frasca V; Inghilleri M
    Funct Neurol; 2017; 32(1):35-40. PubMed ID: 28380322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis.
    Zhang H; Chen L; Tian J; Fan D
    BMC Neurol; 2021 Oct; 21(1):405. PubMed ID: 34686150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a new ALS specific respiratory questionnaire: the ARES score.
    Heiman-Patterson TD; Sherman MS; Yu D; Jackson CE; George A; Kasarskis EJ;
    Amyotroph Lateral Scler Frontotemporal Degener; 2021; 22(sup1):48-53. PubMed ID: 34348538
    [No Abstract]   [Full Text] [Related]  

  • 35. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis.
    Peric' S; Rakocevic-Stojanovic V; Stevic Z; Basta I; Pavlovic S; Vujanac V; Marjanovic L; Lavrnic D
    Acta Neurol Belg; 2010 Mar; 110(1):71-7. PubMed ID: 20514929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis.
    Mandrioli J; Ferri L; Fasano A; Zucchi E; Fini N; Moglia C; Lunetta C; Marinou K; Ticozzi N; Drago Ferrante G; Scialo C; Sorarù G; Trojsi F; Conte A; Falzone YM; Tortelli R; Russo M; Sansone VA; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Monsurrò MR; Sabatelli M; Chiò A; Riva N; Logroscino G; Messina S; Calvo A
    Eur J Neurol; 2018 Jun; 25(6):861-868. PubMed ID: 29512869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis.
    Cellura E; Spataro R; Taiello AC; La Bella V
    Clin Neurol Neurosurg; 2012 Jul; 114(6):550-4. PubMed ID: 22169158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis.
    Simon NG; Lee M; Bae JS; Mioshi E; Lin CS; Pfluger CM; Henderson RD; Vucic S; Swash M; Burke D; Kiernan MC
    J Neurol; 2015 Jun; 262(6):1424-32. PubMed ID: 25845764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.